277 related articles for article (PubMed ID: 12692401)
1. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
Padmanabhan R; Shafiullah MM
Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
[TBL] [Abstract][Full Text] [Related]
2. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.
Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N
Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836
[TBL] [Abstract][Full Text] [Related]
3. Metabolite profiling of whole murine embryos reveals metabolic perturbations associated with maternal valproate-induced neural tube closure defects.
Akimova D; Wlodarczyk BJ; Lin Y; Ross ME; Finnell RH; Chen Q; Gross SS
Birth Defects Res; 2017 Jan; 109(2):106-119. PubMed ID: 27860192
[TBL] [Abstract][Full Text] [Related]
4. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
Padmanabhan R; Hameed MS
J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
Nau H; Hauck RS; Ehlers K
Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
[TBL] [Abstract][Full Text] [Related]
6. [Morphological changes induced by valproate and its administration concomitant with folinic acid or S-adenosylmethionine in pregnant rats].
Ubeda-Martín N; Alonso-Aperte E; Achón M; Varela-Moreiras G; Puerta J; Pérez de Miguelsanz J
Nutr Hosp; 1998; 13(1):41-9. PubMed ID: 9578686
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation rescues valproic acid-induced developmental neurotoxicity and behavioral alterations in zebrafish embryos.
Muhsen M; Youngs J; Riu A; Gustafsson JÅ; Kondamadugu VS; Garyfalidis E; Bondesson M
Epilepsia; 2021 Jul; 62(7):1689-1700. PubMed ID: 33997963
[TBL] [Abstract][Full Text] [Related]
8. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
Dawson JE; Raymond AM; Winn LM
Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcome in ethanol-treated mice with folic acid supplementation in saccharose.
Yanaguita MY; Gutierrez CM; Ribeiro CN; Lima GA; Machado HR; Peres LC
Childs Nerv Syst; 2008 Jan; 24(1):99-104. PubMed ID: 17619885
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
11. Valproate and folate: Congenital and developmental risks.
Reynolds EH; Green R
Epilepsy Behav; 2020 Jul; 108():107068. PubMed ID: 32375098
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice.
Elmazar MM; Nau H
Teratog Carcinog Mutagen; 1992; 12(5):203-10. PubMed ID: 1363493
[TBL] [Abstract][Full Text] [Related]
13. Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations in TO mouse fetuses [corrected].
Padmanabhan R; Ahmed I
Reprod Toxicol; 1996; 10(5):345-63. PubMed ID: 8888407
[TBL] [Abstract][Full Text] [Related]
14. Etiology, pathogenesis and prevention of neural tube defects.
Padmanabhan R
Congenit Anom (Kyoto); 2006 Jun; 46(2):55-67. PubMed ID: 16732763
[TBL] [Abstract][Full Text] [Related]
15. Prevention of valproic acid-induced neural tube defects by sildenafil citrate.
Tiboni GM; Ponzano A
Reprod Toxicol; 2015 Aug; 56():175-9. PubMed ID: 25797655
[TBL] [Abstract][Full Text] [Related]
16. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
Elmazar MM; Thiel R; Nau H
Fundam Appl Toxicol; 1992 Apr; 18(3):389-94. PubMed ID: 1597263
[TBL] [Abstract][Full Text] [Related]
17. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
[TBL] [Abstract][Full Text] [Related]
18. Valproate-induced neural tube defects in folate-binding protein-2 (Folbp2) knockout mice.
Spiegelstein O; Merriweather MY; Wicker NJ; Finnell RH
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):974-8. PubMed ID: 14745917
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid effect on neural tube defects is not prevented by concomitant folic acid supplementation: Early chick embryo model pilot study.
Turgut U; Kazan S; Cakin H; Ozak A
Int J Dev Neurosci; 2019 Nov; 78():45-48. PubMed ID: 31376429
[TBL] [Abstract][Full Text] [Related]
20. Insights into prevention of human neural tube defects by folic acid arising from consideration of mouse mutants.
Harris MJ
Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):331-9. PubMed ID: 19117321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
